Serotonin syndrome risk — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Increased serotonergic toxicity risk
St John's wort interacts with SSRIs and can increase serotonin toxicity risk while also inducing drug metabolism. The sale should be discouraged and the patient referred for clinical review. In this scenario, the correct option is increased serotonergic toxicity risk. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.
Reference: BNF; Stockley's Drug Interactions